|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Costs, expenses, and other: | |||||
| Cost of sales | |||||
| Research and development | |||||
| Marketing, selling, and administrative | |||||
| Acquired in-process research and development | |||||
| Asset impairment, restructuring, and other special charges | |||||
| Other—net, (income) expense | |||||
| Costs, expenses, and other | |||||
| Income before income taxes | |||||
| Income taxes | |||||
| Net income | |||||
| Earnings per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Shares used in calculation of earnings per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...